SCHEMBL31135339

SCHEMBL31135339

C[Si](C)(C)C#Cc1cc(Cl)ccc1O

nearest known ligand 0.42

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
HSD17B10 Q99714 4/20 0.42
TSHR P16473 2/20 0.42
ALDH1A1 P00352 4/20 0.39
HPGD P15428 3/20 0.39
ALOX15 P16050 3/20 0.39
ALOX12 P18054 2/20 0.39
SMN1; SMN2 Q16637 2/20 0.39
MAPK1 P28482 2/20 0.39
IDO1 P14902 6/20 0.38
MEN1 O00255 4/20 0.38
KMT2A Q03164 4/20 0.38
CYP3A4 P08684 3/20 0.38
HIF1A Q16665 3/20 0.38
HTT P42858 3/20 0.38
HSP90AA1 P07900 2/20 0.38
CYP2C9 P11712 2/20 0.38
CYP2C19 P33261 2/20 0.38
CASP1 P29466 2/20 0.38
MAPT P10636 2/20 0.38
SLC22A1 O15245 1/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL22955864 1.00 HSD17B10 (0.42) HSD17B10TSHRALDH1A1HPGDALOX15
SCHEMBL15462385 0.81 NR1H3 (0.43) HSD17B10TSHRALDH1A1HPGDALOX15
SCHEMBL29172852 0.81 TP53 (0.39) HSD17B10TSHRALDH1A1CYP3A4TDP1
SCHEMBL1544552 0.79 PTGDR2 (0.36) HSD17B10TSHRALDH1A1HPGDMEN1
SCHEMBL14917306 0.78 CYP3A4 (0.43) HSD17B10TSHRALDH1A1HPGDALOX15
SCHEMBL3871076 0.78 PDE10A (0.44) HSD17B10TSHRALDH1A1HPGDALOX15
SCHEMBL17792036 0.78 PYCR1 (0.31)
SCHEMBL30250354 0.78 CYP3A4 (0.43) HSD17B10TSHRALDH1A1HPGDALOX15
SCHEMBL2462934 0.77 TP53 (0.39) HSD17B10TSHRALDH1A1HPGDALOX15
SCHEMBL25251254 0.76 MAOA (0.46) ALDH1A1HPGDMEN1KMT2AMAPT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2024222614-A1 HETEROCYCLIC GSPT1 DEGRADATION AGENT 北京诺诚健华医药科技有限公司 2024-10-31 WO disclosed